Table 2.
Pathogen—LAB interactions studied in the C. elegans intestine.
| Kingdoms | Pathogens | LABs | Mechanisms | References |
|---|---|---|---|---|
| Bacteria | S. enterica |
L. helveticus
L. plantarum L. rhamnosus B. infantis B. longum E. faecium |
Immunotolerance Not described Not described |
(84) (132) (35) |
| P. aeruginosa |
L. brevis
P. acidilatici P. pentosaceus |
Not described | (32) | |
| S. aureus |
L. plantarum
L. zeae L. casei L. rhamnosus L. acidophilus |
Not described TIR-1, PMK-1 and BAR-1 pathways |
(74) (160) |
|
|
E. coli (clinical isolates) |
L. plantarum
L. paracasei |
Not described Not described |
(154) (89) |
|
| ETEC |
L. zeae
L. casei L. plantarum L. rhamnosus |
Inhibition of E. coli virulence Not described |
(155) (36) |
|
| EHEC |
E. faecalis
L. acidophilus |
Inhibition of virulence Inhibition of virulence |
(156) (157) |
|
| L. pneumophila | B. infantis | p38 MAPK pathway | (159) | |
| E. faecalis | L. acidophilus | TIR-1, PMK-1 and BAR-1 pathways | (160) | |
| Fungi | C. albicans |
L. rhamnosus
L. paracasei |
DAF-16 and p38 MAPK pathway Filamentation inhibition |
(90, 150) (151) |